Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis

Antiphospholipid antibodies (aPL) may occur alone or associated with other diseases. To evaluate aPL, tested as anticardiolipin antibodies (IgG aCL) in infective endocarditis (IE) diagnosis, we investigated their prevalence in a cohort of 651 patients with IE suspicion. aPL was significantly associa...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases Vol. 36; no. 7; pp. 1159 - 1162
Main Authors: Zaratzian, C., Gouriet, F., Tissot-Dupont, H., Casalta, J.-P., Million, M., Bardin, N., Grisoli, D., Habib, G., Raoult, D.
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-07-2017
Springer Nature B.V
Springer Verlag
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antiphospholipid antibodies (aPL) may occur alone or associated with other diseases. To evaluate aPL, tested as anticardiolipin antibodies (IgG aCL) in infective endocarditis (IE) diagnosis, we investigated their prevalence in a cohort of 651 patients with IE suspicion. aPL was significantly associated with definite IE versus IE-rejected patients. Their mean levels were significantly higher in patients with definite IE versus possible IE. When applied as Duke minor criterion, they were significantly more often positive, and at higher levels, in patients with definite IE than in patients with possible or rejected IE. aPL could be helpful in difficult cases of IE diagnosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0934-9723
1435-4373
DOI:10.1007/s10096-017-2903-1